Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 129, 2023 - Issue 3
268
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Sex differences in the association between obesity and hypertension

ORCID Icon & ORCID Icon
Pages 682-689 | Received 07 Oct 2020, Accepted 03 Dec 2020, Published online: 21 Jan 2021

References

  • Briant, L.J., Charkoudian, N., and Hart, E.C., 2016. Sympathetic regulation of blood pressure in normotension and hypertension: when sex matters. Experimental physiology, 101 (2), 219–229.
  • Brooks, V.L., et al., 2015. Obesity-induced increases in sympathetic nerve activity: sex matters. Autonomic neuroscience: basic & clinical, 187, 18–26.
  • Chan, L., et al., 2016. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in patients with adult growth hormone deficiency. Experimental and clinical endocrinology & diabetes, 124 (04), 220–224.
  • Chrysant, S.G., 2019. Pathophysiology and treatment of obesity-related hypertension. Journal of clinical hypertension (Greenwich, Conn.), 21 (5), 555–559.
  • Colafella, K.M.M. and Denton, K.M., 2018. Sex-specific differences in hypertension and associated cardiovascular disease. Nature reviews. Nephrology, 14 (3), 185–201.
  • Dai, D., et al., 2016. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in northeast China. International journal of environmental research and public health, 13 (12), 1231.
  • Dobiásová, M. and Frohlich, J., 2001. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clinical biochemistry, 34 (7), 583–588.
  • Dorresteijn, J.A., Visseren, F.L., and Spiering, W., 2012. Mechanisms linking obesity to hypertension. Obesity reviews: an official journal of the international association for the study of obesity, 13 (1), 17–26.
  • Dubey, R.K., et al., 2002. Sex hormones and hypertension. Cardiovascular research, 53 (3), 688–708.
  • Echem, C., et al., 2019. Mitochondrial DNA: a new driver for sex differences in spontaneous hypertension. Pharmacological research, 144, 142–150.
  • Fappi, A. and Mittendorfer, B., 2020. Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women. The proceedings of the nutrition society, 79 (2), 210–218.
  • Faulkner, J.L. and Belin de Chantemèle, E.J., 2018. Sex differences in mechanisms of hypertension associated with obesity. Hypertension (Dallas, TX: 1979), 71 (1), 15–21.
  • Fu, Q., 2019. Sex differences in sympathetic activity in obesity and its related hypertension. Annals of the New York academy of sciences, 1454 (1), 31–41.
  • Ganguly, S., et al., 2018. Lipid accumulation product index as visceral obesity indicator in psoriasis: a case-control study. Indian journal of dermatology, 63 (2), 136–140.
  • Gao, X., et al., 2013. Comparison of lipid accumulation product with body mass index as an indicator of hypertension risk among Mongolians in China. Obesity research & clinical practice, 7 (4), e308–e314.
  • Glintborg, D. and Andersen, M., 2017. Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review. Current opinion in obstetrics & gynecology, 29 (6), 390–396.
  • Gohar, E.Y. and Pollock, D.M., 2018. Sex-specific contributions of endothelin to hypertension. Current hypertension reports, 20 (7), 58.
  • Gupte, M., et al., 2012. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arteriosclerosis, thrombosis, and vascular biology, 32 (6), 1392–1399.
  • Halperin, R.O., et al., 2006. Dyslipidemia and the risk of incident hypertension in men. Hypertension (Dallas, TX: 1979), 47 (1), 45–50.
  • Haslam, D.W. and James, W.P., 2005. Obesity. The lancet, 366 (9492), 1197–1209.
  • Hokanson, J.E. and Austin, M.A., 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of cardiovascular risk, 3 (2), 213–219.
  • Ioachimescu, A.G., et al., 2010. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity, 18 (9), 1836–1844.
  • Kahn, H.S., 2005. The lipid accumulation product is better than body mass index for identifying diabetes. American journal of epidemiology, 161 (Supplement_1), S51–S51.
  • Kaneva, A.M. and Bojko, E.R., 2019. Lipid accumulation product or lap as an up-to-date clinical biochemical marker of human obesity. Health risk analysis, 2 (2), 164–173.
  • Lee, S.H., et al., 2005. A retrospective cohort study on obesity and hypertension risk among Korean adults. Journal of Korean medical science, 20 (2), 188–195.
  • Li, R., et al., 2017. Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese. Scientific reports, 7 (1), 7951.
  • Marcadenti, A., et al., 2017. Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference. Atherosclerosis, 266, 145–150.
  • Maric-Bilkan, C. and Manigrasso, M.B., 2012. Sex differences in hypertension: contribution of the renin-angiotensin system. Gender medicine, 9 (4), 287–291.
  • National Cholesterol Education Program (NCEP). 2002. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III) Final Report, 106, 3143–3421. Circulation,
  • Otsuka, T., et al., 2016. Dyslipidemia and the risk of developing hypertension in a working-age male population. Journal of the American heart association, 5 (3), e003053.
  • Pirro, M., et al., 2008. Hypercholesterolemia-associated endothelial progenitor cell dysfunction. Therapeutic advances in cardiovascular disease, 2 (5), 329–339.
  • Re, R.N., 2009. Obesity-related hypertension. The Ochsner journal, 9 (3), 133–136.
  • Reckelhoff, J.F., et al., 2019. Sex, oxidative stress, and hypertension: insights from animal models. Physiology (Bethesda, Md.), 34 (3), 178–188.
  • Seravalle, G. and Grassi, G., 2017. Obesity and hypertension. Pharmacological research, 122, 1–7.
  • Song, J., et al., 2018. Risk factors for prehypertension and their interactive effect: a cross- sectional survey in China. BMC cardiovascular disorders, 18 (1), 182.
  • Stensvold, I., et al., 1992. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. European heart journal, 13 (9), 1155–1163.
  • Sullivan, J.C., 2008. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. American journal of physiology. Regulatory, integrative and comparative physiology, 294 (4), R1220–R1226.
  • Syamsunder, A.N., et al., 2017. Decreased baroreflex sensitivity is linked to the atherogenic index, retrograde inflammation, and oxidative stress in subclinical hypothyroidism. Endocrine research, 42 (1), 49–58.
  • Sylvester, M.A. and Brooks, H.L., 2019. Sex-specific mechanisms in inflammation and hypertension. Current hypertension reports, 21 (7), 53.
  • Tanaka, M. and Itoh, H., 2019. Hypertension as a metabolic disorder and the novel role of the gut. Current hypertension reports, 21 (8), 63.
  • Wakabayashi, I., 2014. Influence of age and gender on lipid accumulation product and its relation to diabetes mellitus in Japanese. Clinica chimica acta, 431, 221–226.
  • Wang, H., et al., 2018. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgraduate medicine, 130 (3), 325–333.
  • Wen, J., et al., 2019. Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population. Hypertension research, 42 (8), 1223–1230.
  • Wilkinson, I. and Cockcroft, J.R., 2007. Cholesterol, lipids and arterial stiffness. Advances in cardiology, 44, 261–277.
  • Wolfrum, S., Jensen, K.S., and Liao, J.K., 2003. Endothelium-dependent effects of statins. Arteriosclerosis, thrombosis, and vascular biology, 23 (5), 729–736.
  • Wolk, R., Shamsuzzaman, A.S., and Somers, V.K., 2003. Obesity, sleep apnea, and hypertension. Hypertension (Dallas, Tex.: 1979), 42 (6), 1067–1074.
  • Yang, Y.D., et al., 2019. Sex difference in the mediation roles of an inflammatory factor (hsCRP) and adipokines on the relationship between adiposity and blood pressure. Hypertension research, 42 (6), 903–911.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.